Pieris Pharmaceuticals In...
(PIRS)
undefined
undefined%
At close: undefined
13.26
0.00%
After-hours Dec 13, 2024, 04:03 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 17.40M | 38.63M | 117.76M | 70.44M | 62.26M | 74.87M | 37.88M | 29.36M | 29.35M | 18.47M | 3.69M | 6.33M |
| Short-Term Investments | 8.97M | 20.53M | - | - | 41.89M | 53.24M | 34.75M | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - | 9.92M | - | - | - | - | - |
| Other Long-Term Assets | - | 1.37M | 2.90M | 3.31M | 3.15M | 910.00K | 130.00K | 125.74K | 126.78K | - | - | -2.67M |
| Receivables | 572.00K | 5.81M | 3.31M | 1.71M | 6.79M | 2.70M | 15.55M | 57.00K | - | - | 743.38K | 971.36K |
| Inventory | - | - | - | 1.00 | - | 1.00 | - | - | -980.94K | 1.00 | 72.50K | 1.00 |
| Other Current Assets | 11.74M | 8.45M | 13.10M | 7.16M | 8.14M | 9.15M | 3.23M | 3.26M | 1.31M | 1.33M | 387.62K | 566.87K |
| Total Current Assets | 38.68M | 73.42M | 127.63M | 75.72M | 115.01M | 135.38M | 89.79M | 32.67M | 31.66M | 19.81M | 4.82M | 7.87M |
| Property-Plant & Equipment | - | 20.70M | 23.03M | 25.98M | 22.94M | 5.05M | 4.03M | 2.26M | 2.16M | 2.05M | 2.44M | 2.67M |
| Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Long-Term Assets | - | 22.07M | 25.93M | 29.29M | 26.08M | 5.96M | 14.09M | 2.39M | 2.29M | 2.08M | 2.46M | 2.67M |
| Total Assets | 38.68M | 95.49M | 153.56M | 105.01M | 141.10M | 141.34M | 103.88M | 35.06M | 33.95M | 21.88M | 7.28M | 10.57M |
| Account Payables | 3.37M | 4.15M | 8.61M | 1.79M | 5.80M | 3.35M | 2.45M | 2.39M | 1.06M | 1.26M | 278.01K | 813.67K |
| Deferred Revenue | - | 20.82M | 25.12M | 12.63M | 11.26M | 35.61M | 37.15M | 2.27M | - | 770.39K | 544.56K | - |
| Short-Term Debt | - | 859.00K | 1.05M | 1.03M | 733.00K | - | - | - | - | 1.27M | 206.49K | - |
| Other Current Liabilities | 8.55M | 10.75M | 15.79M | 6.57M | 8.69M | 8.74M | 5.75M | 5.54M | 1.56M | 986.62K | 738.99K | 8.44M |
| Total Current Liabilities | 11.92M | 36.58M | 50.56M | 22.14M | 27.00M | 48.08M | 45.77M | 8.38M | 2.80M | 3.54M | 1.77M | 9.25M |
| Long-Term Debt | - | 12.24M | 13.84M | 15.93M | 15.48M | - | - | - | - | - | 4.54M | - |
| Other Long-Term Liabilities | - | - | - | 6.00K | - | 27.00K | 37.00K | 1.46M | 23.85K | 333.99K | 379.94K | - |
| Total Long-Term Liabilities | - | 30.98M | 52.24M | 51.84M | 62.74M | 53.33M | 46.58M | 1.46M | 23.85K | 333.99K | 4.92M | - |
| Total Liabilities | 11.92M | 67.56M | 102.81M | 73.98M | 89.75M | 101.41M | 92.35M | 9.84M | 2.82M | 3.88M | 6.69M | 9.25M |
| Total Debt | - | 13.10M | 13.84M | 16.96M | 16.22M | - | - | - | - | 1.27M | 4.75M | - |
| Common Stock | 98.00K | 74.00K | 72.00K | 56.00K | 55.00K | 54.00K | 45.00K | 43.06K | 39.83K | 29.28K | 11.83K | 53.89K |
| Retained Earnings | -314.96M | -290.42M | -257.14M | -211.41M | -174.18M | -147.07M | -120.31M | -102.66M | -79.87M | -65.81M | -55.96M | -56.02M |
| Comprehensive Income | 28.00K | -254.00K | 829.00K | -295.00K | -2.00M | -2.98M | -4.70M | -1.50M | -1.27M | -843.10K | -956.27K | - |
| Shareholders Equity | 26.76M | 27.93M | 50.76M | 31.03M | 51.35M | 39.94M | 11.52M | 25.23M | 31.13M | 18.01M | 585.01K | 495.70K |
| Total Investments | 8.97M | 20.53M | - | - | 41.89M | 53.24M | 44.67M | - | - | - | - | - |